期刊文献+

Synthesis and Anti-tumor Evaluation of B-ring Modified Caged Xanthone Analogues of Gambogic Acid 被引量:1

Synthesis and Anti-tumor Evaluation of B-ring Modified Caged Xanthone Analogues of Gambogic Acid
原文传递
导出
摘要 Gambogic acid (GA, 1), the most prominent member of Garcinia natural products, has been reported to be a promising anti-tumor agent. Previous studies have suggested that the planar B ring and the unique 4-oxa-tricyclo- [4.3.1.03.7]dec-2-one caged motif were essential for anti-tumor activity. To further explore the structure-activity relationship (SAR) of caged Garcinia xanthones, two new series of B-ring modified caged GA analogues 13a-13e and 15a-lge were synthesized utilizing a Claisen/Diel-Alder cascade reaction. Subsequently, these compounds were evaluated for their in vitro antitumor activities against A549, MCF-7, SMMC-7721 and BGC-823 cancer cell lines by MTT assay. Among them, 13b-13e exhibited micromolar inhibition against several cancer cell lines, being approximately 2-4 fold less potent in comparison to GA. SAR analysis revealed that the peripheral gem-dimethyl groups are essential for maintaining antitumor activity and substituent group on C1 position of B-ring has a significant effect on potency, while modifications at C-2, C-3 and C-4 positions are relatively tolerated. These findings will enhance our understanding of the SAR of Garcinia xanthones and lead to the development of simplified analogues as potential anti-tumor agents. Gambogic acid (GA, 1), the most prominent member of Garcinia natural products, has been reported to be a promising anti-tumor agent. Previous studies have suggested that the planar B ring and the unique 4-oxa-tricyclo- [4.3.1.03.7]dec-2-one caged motif were essential for anti-tumor activity. To further explore the structure-activity relationship (SAR) of caged Garcinia xanthones, two new series of B-ring modified caged GA analogues 13a-13e and 15a-lge were synthesized utilizing a Claisen/Diel-Alder cascade reaction. Subsequently, these compounds were evaluated for their in vitro antitumor activities against A549, MCF-7, SMMC-7721 and BGC-823 cancer cell lines by MTT assay. Among them, 13b-13e exhibited micromolar inhibition against several cancer cell lines, being approximately 2-4 fold less potent in comparison to GA. SAR analysis revealed that the peripheral gem-dimethyl groups are essential for maintaining antitumor activity and substituent group on C1 position of B-ring has a significant effect on potency, while modifications at C-2, C-3 and C-4 positions are relatively tolerated. These findings will enhance our understanding of the SAR of Garcinia xanthones and lead to the development of simplified analogues as potential anti-tumor agents.
出处 《Chinese Journal of Chemistry》 SCIE CAS CSCD 2012年第1期35-42,共8页 中国化学(英文版)
基金 This work was supported by 90713038 and 21072231 of National Natural Science Foundation of China (Key Program), 2008ZX09401-001, 2009ZX09501-003 and 2010ZX09401-401 of National Major Science and Technology Project of China (Innovation and Development of New Drugs).
关键词 4-oxa-tricyclo[4.3.1.03.7]dec-2-0ne gambogic acid SYNTHESIS anti-tumor activity SAR studies 4-oxa-tricyclo[4.3.1.03.7]dec-2-0ne, gambogic acid, synthesis, anti-tumor activity, SAR studies
  • 相关文献

参考文献29

  • 1Auterhoff; H.; Frauendorf, H.; Liesenklas, W.; Schwandt, C. Arch Pharm. 1962, 295, 833.
  • 2Kumar, P.; Baslas, R. K. Herba Hungarica 1980, 19, 81.
  • 3Ollis, W. D.; Ramsay, M. V. J.; Sutherland, 1. O.; Mongkolsuk, S Tetrahedron 1965, 21, 1453.
  • 4Asano, J.; Chiba, K.; Tada, M.; Yoshii, T. Photochemistry 1996, 41 815.
  • 5Han. Q. B.; Xu, H. X. Curr. Med. Chem. 2009, 16, 3775.
  • 6Wu, Z. Q.; Guo, Q. L.; You, Q. D.; Zhao, L.; Gu, H. Y. Biol. Pharm. Bull. 2004, 27, 1769.
  • 7Zhang, H. Z.; Kasibhatla, S.; Wang, J.; Herich, J.; Guastella, J.; Tseng, B.; Drewe, J.; Cai, S. X. Bioorg. Med. Chem. 2004, 12, 309.
  • 8Zhao, L.; Zhen, C.; Wu, Z. Q.; Hu, R.; Zhou, C. L.; Guo, Q. L. Drug Chem. Toxicol. 2010, 33, 86.
  • 9Zhao, L.; Guo, Q. L.; You, Q. D.; Wu, Z. Q.; Gu, H. Y. Biol. Pharm. Bull. 2004, 27, 998.
  • 10Li, Q.; Cheng, H.; Zhu, G.; Yang, L.; Zhou, A.; Wang, X.; Fang, N.; Xia, L.; Su, J.; Wang, M.; Peng, D.; Xu, Q. Biol. Pharm. Bull. 2010, 33,415.

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部